ARTICLES BY THIS AUTHOR
- 1/22/2020
Alembic gets FDA nod for generic Zanaflex
Tizanidine hydrochloride had a market value of roughly $28 million for the 12 months ended September 2019, according to IQVIA. - 1/22/2020
Hy-Vee to open second Wahlburgers in Minnesota
Hy-Vee is opening its sixth Wahlburgers franchise location in Maple Grove, Minn. - 1/22/2020
Ironwood, Allergan settle patent suit with Teva
The earliest licensed entry of any generic linaclotide 145 mcg or 290 mcg Linzess is March 2029. - 1/22/2020
Rite Aid Foundation welcomes 481 nonprofit organizations to KidCents program
The Rite Aid Foundation is providing more than $2.4 million in grant funding to 481 nonprofits. - 1/22/2020
NACDS to CMS: Executive Order 13890 relies on leveraging pharmacy
NACDS’ comments to CMS demonstrate that success of healthcare transformation relies on removing barriers to pharmacy care. - 1/22/2020
PQA names 2020 board and executive committee
PQA appointed Linda Garrelts MacLean and Michael Taday to its 21-member board, as well as named a new executive board. - 1/21/2020
Mockingbird Pharma receives NCDQS accreditation
Mockingbird Pharma is the second facility to meet NCDQS' strict accreditation approval criteria. - 1/21/2020
NCPA to CMS: Recognize pharmacist services beyond dispensing
The National Community Pharmacists Association is urging CMS to allow pharmacists to practice at the top of their licenses. - 1/21/2020
Rapid uptake in generics, biosimilars are key in improving medicine access
Although polices have been introduced to increase the use of generics and biosimilars, large differences remain in the price and uptake of these medicines between countries. - 1/21/2020
FDA clears Horizon Therapeutics’ Tepezza
Tepezza is the first approved treatment for thyroid eye disease.